• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次血液嗜酸性粒细胞计数是否是“嗜酸性粒细胞性哮喘”的可靠标志物?

Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?".

作者信息

Spector Sheldon Laurence, Tan Ricardo Antonio

机构信息

Department of Medicine, UCLA Medical Center, Los Angeles, CA 90095, USA.

出版信息

J Asthma. 2012 Oct;49(8):807-10. doi: 10.3109/02770903.2012.713428. Epub 2012 Aug 20.

DOI:10.3109/02770903.2012.713428
PMID:22900679
Abstract

INTRODUCTION

"Eosinophilic asthma" refers to an asthma phenotype characterized by predominance of eosinophils in the bronchial airways and corticosteroid responsiveness. Recent clinical trials of eosinophil-blocking agents have utilized a blood eosinophil count of 300 or 400 eosinophils/mm(3) or higher to identify subjects with moderate to severe asthma. We observed multiple instances of counts which varied widely in the same patient within the same day.

OBJECTIVES

To determine whether there is significant variability in blood eosinophil counts taken throughout the day in the same patients with moderate asthma.

METHODS

Twelve subjects had serial blood eosinophil counts obtained within a 24-hour period.

RESULTS

Twelve subjects were enrolled: seven subjects had moderate asthma, three subjects had mild asthma, and two control subjects had no asthma. The variability of blood eosinophil counts ranged from 17% to 396%. No specific diurnal pattern was found among the subjects. The highest variability were seen in three moderate asthmatics (396%, 170%, and 154%) and one mild asthmatic (164%) while the other subjects had variability of 84% or less.

CONCLUSIONS

This study showed significant variability in blood eosinophil counts within a 24-hour period in the same subjects. The highest variability was seen in moderate asthmatics. These findings would appear to place the utility of a single eosinophil count in question.

摘要

引言

“嗜酸性粒细胞性哮喘”是指一种哮喘表型,其特征为支气管气道中嗜酸性粒细胞占优势且对皮质类固醇有反应。嗜酸性粒细胞阻滞剂的近期临床试验利用血液嗜酸性粒细胞计数300或400个嗜酸性粒细胞/mm³或更高来识别中度至重度哮喘患者。我们观察到同一患者在同一天内计数多次出现大幅波动的情况。

目的

确定中度哮喘患者同一天内全天的血液嗜酸性粒细胞计数是否存在显著变异性。

方法

12名受试者在24小时内进行了系列血液嗜酸性粒细胞计数。

结果

共纳入12名受试者:7名中度哮喘患者,3名轻度哮喘患者,2名对照受试者无哮喘。血液嗜酸性粒细胞计数的变异性范围为17%至396%。受试者中未发现特定的昼夜模式。变异性最高的是3名中度哮喘患者(396%、170%和154%)和1名轻度哮喘患者(164%),而其他受试者的变异性为84%或更低。

结论

本研究表明同一受试者在24小时内血液嗜酸性粒细胞计数存在显著变异性。变异性最高的是中度哮喘患者。这些发现似乎使单次嗜酸性粒细胞计数的实用性受到质疑。

相似文献

1
Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?".单次血液嗜酸性粒细胞计数是否是“嗜酸性粒细胞性哮喘”的可靠标志物?
J Asthma. 2012 Oct;49(8):807-10. doi: 10.3109/02770903.2012.713428. Epub 2012 Aug 20.
2
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.血液嗜酸性粒细胞计数是一种有用的生物标志物,可用于识别患有严重嗜酸性粒细胞性哮喘的患者。
Ann Am Thorac Soc. 2014 May;11(4):531-6. doi: 10.1513/AnnalsATS.201310-354OC.
3
Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children.嗜酸性粒细胞的形态变化是儿童急性哮喘加重严重程度的可靠标志物。
Allergy. 2013 Jul;68(7):911-20. doi: 10.1111/all.12176. Epub 2013 Jun 7.
4
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.通过有创和无创方法评估的重度哮喘气道炎症:嗜酸性粒细胞和非嗜酸性粒细胞表型
J Allergy Clin Immunol. 2006 Nov;118(5):1033-9. doi: 10.1016/j.jaci.2006.08.003. Epub 2006 Sep 25.
5
Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity.嗜酸性粒细胞阳离子蛋白/嗜酸性粒细胞计数比值在哮喘患者中的意义:其与疾病严重程度的关系。
Ann Allergy Asthma Immunol. 2001 Mar;86(3):323-9. doi: 10.1016/S1081-1206(10)63307-8.
6
The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.孟鲁司特治疗对哮喘儿童血清白细胞介素-10水平、嗜酸性粒细胞阳离子蛋白、血液嗜酸性粒细胞计数及临床参数的影响。
Turk J Pediatr. 2009 Sep-Oct;51(5):460-5.
7
Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.对不同严重程度哮喘儿童血清中的嗜酸性粒细胞增多症及嗜酸性粒细胞阳离子蛋白(ECP)进行评估。
Allergol Immunopathol (Madr). 1999 Nov-Dec;27(6):304-8.
8
Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients.轻度哮喘患者中,迟发性哮喘反应对变应原的强度与基线及变应原诱导的痰液嗜酸性粒细胞增多的关系。
Ann Allergy Asthma Immunol. 2008 May;100(5):457-62. doi: 10.1016/S1081-1206(10)60471-1.
9
Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.血清嗜酸性粒细胞阳离子蛋白作为急性和慢性哮喘疾病活动的预测指标。
East Afr Med J. 1999 Sep;76(9):524-9.
10
Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.尿嗜酸性粒细胞衍生神经毒素/蛋白X:一种评估体内嗜酸性粒细胞脱颗粒的简单方法。
J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):116-23. doi: 10.1016/S0091-6749(98)70202-7.

引用本文的文献

1
Differences in Blood Eosinophil Level During Stable Disease and During Exacerbation of COPD and Exacerbation Risks.慢性阻塞性肺疾病稳定期与急性加重期的血嗜酸性粒细胞水平差异及急性加重风险
Lung. 2025 Feb 27;203(1):37. doi: 10.1007/s00408-025-00792-9.
2
Eosinophil count and clinical outcome in patients with acute exacerbation of Chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者的嗜酸性粒细胞计数与临床结局
J Prev Med Hyg. 2024 Oct 31;65(3):E389-E394. doi: 10.15167/2421-4248/jpmh2024.65.3.3267. eCollection 2024 Sep.
3
Systematic review: differences in complete blood count component rhythms.
系统评价:全血细胞计数各成分节律的差异
Sleep Adv. 2024 Dec 9;5(1):zpae086. doi: 10.1093/sleepadvances/zpae086. eCollection 2024.
4
Εosinophilic Chronic Obstructive Pulmonary Disease. What Do We Know So Far?嗜酸性慢性阻塞性肺疾病。我们目前了解到了什么?
Pulm Ther. 2025 Mar;11(1):7-24. doi: 10.1007/s41030-024-00280-0. Epub 2024 Dec 11.
5
Normal Blood Eosinophil Counts in Humans.人类血液中嗜酸性粒细胞的正常计数
Respiration. 2024;103(4):214-216. doi: 10.1159/000537833. Epub 2024 Feb 14.
6
Eosinophilic Patterns in Patients with Seasonal Allergy Affected by Bronchial Asthma and Rhinitis/Rhinosinusitis: Efficacy of Benralizumab in Patients with the Persistent Pattern.季节性过敏合并支气管哮喘和鼻炎/鼻-鼻窦炎患者的嗜酸性粒细胞模式:贝那利珠单抗对持续性模式患者的疗效
J Clin Med. 2024 Jan 28;13(3):754. doi: 10.3390/jcm13030754.
7
Is fractional exhaled nitric oxide a treatable trait in chronic cough: a narrative review.呼出一氧化氮分数在慢性咳嗽中是否为可治疗的特征:一项叙述性综述
J Thorac Dis. 2023 Oct 31;15(10):5844-5855. doi: 10.21037/jtd-23-135. Epub 2023 Oct 24.
8
Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease.稳定期血嗜酸性粒细胞计数的变异性预测慢性阻塞性肺疾病加重风险。
Int J Chron Obstruct Pulmon Dis. 2023 Jun 12;18:1145-1153. doi: 10.2147/COPD.S401357. eCollection 2023.
9
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.哮喘和伴或不伴鼻息肉的慢性鼻-鼻窦炎的病理生理学和治疗靶点的新见解。
Clin Sci (Lond). 2023 May 18;137(9):727-753. doi: 10.1042/CS20190281.
10
Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study.稳定期慢性阻塞性肺疾病患者循环嗜酸性粒细胞水平与肺功能下降的关系:一项回顾性纵向研究。
J Bras Pneumol. 2022 Dec 2;48(6):e20220183. doi: 10.36416/1806-3756/e20220183. eCollection 2022.